13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001535610
Total reported value
$110.5M
$110.5M
55 檔
8.7%
As reported in its official Q1 2024 Form 13F filing, Sabby Management, LLC's tracked investment portfolio stood at $110.5M with 55 total positions.
During Q1 2024, Sabby Management, LLC's portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
In terms of portfolio concentration, the top 5 core holdings (including VANI, ELTEK LTD, CORZ 12 01-23-29) accounted for 8.7% of total reported equity market value during Q1 2024.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | VANI | Vivani Medical Inc | Stock-Other | 26.90% | — | — | |
| 2 | ✓ | Eltek LTD | Stock-Other | 6.85% | — | — | |
| 3 | CORZ 12 01-23-29Bond | Core Scientific Inc | Bond | 6.77% | — | — | |
| 4 | RDHL | Redhill Biopharma Ltd-sp Adr | Stock-Other | 6.69% | — | — | |
| 5 | TNXPEUR | Tonix Pharmaceuticals Holdin | Stock-Other | 4.95% | — | +58.16% | |
| 6 | ✓ | Spdr S&P 500 Etf Tr Put Option | ETF-Large Cap & Growth | 3.28% | +45.73% | +20.96% | |
| 7 | ✓ | Ishares Tr | Stock-Other | 2.95% | +11.16% | +24.07% | |
| 8 | ✓ | Stock-Other | 2.87% | — | — | ||
| 9 | ✓ | China Natural Resources Inc | Stock-Other | 2.78% | — | — | |
| 10 | ✓ | Checkpoint Therapeutics Inc | Stock-Other | 2.65% | — | +149.26% | |
| 11 | ✓ | Bit Digital Inc | Stock-Other | 2.55% | — | +34.60% | |
| 12 | ✓ | Stock-Other | 2.29% | — | -17.66% | ||
| 13 | ✓ | Biovie Inc | Stock-Other | 1.98% | — | — | |
| 14 | NEXI | Neximmune Inc | Stock-Other | 1.83% | — | — | |
| 15 | AUVI | Applied Uv Inc | Stock-Other | 1.76% | — | — | |
| 16 | ✓ | Globus Maritime Limited New | Stock-Other | 1.74% | — | +22.15% | |
| 17 | SIDU | Sidus Space Inc-cl A | Stock-Other | 1.53% | +0.11% | NEW | |
| 18 | GEVO | Gevo Inc | Stock-Other | 1.46% | — | -3.59% | |
| 19 | SPY | State Street SPDR S&P 500 ETF Trust | ETF-Large Cap & Growth | 1.42% | +13.85% | NEW | |
| 20 | BRTX | Biorestorative Therapies Inc | Stock-Other | 1.27% | — | — | |
| 21 | JCSUSD | Pineapple Energy Inc | Stock-Other | 1.26% | — | — | |
| 22 | ✓ | Stock-Other | 1.24% | — | — | ||
| 23 | ✓ | Glucotrack Inc | Stock-Other | 1.11% | — | +43.30% | |
| 24 | ✓ | Ensysce Biosciences Inc | Stock-Other | 0.99% | — | — | |
| 25 | ✓ | Stock-Other | 0.93% | — | -7.39% | ||
| 26 | ✓ | Ishares Tr | Stock-Other | 0.86% | +12.02% | NEW | |
| 27 | ✓ | Stock-Other | 0.82% | — | +24.92% | ||
| 28 | ✓ | Inmed Pharmaceuticals Inc | Stock-Other | 0.72% | — | -29.34% | |
| 29 | ✓ | Scinai Immunotherapeut Funsponsored Adr 1 Adr Reps 400 Ord Shs | Stock-Other | 0.71% | — | +14.72% | |
| 30 | ✓ | Bynd Cannasoft Enterprises I | Stock-Other | 0.70% | — | — | |
| 31 | ✓ | Processa Pharmaceuticals Inc | Stock-Other | 0.63% | — | — | |
| 32 | ✓ | Briacell Therapeutics CORP | Stock-Other | 0.54% | — | +3.56% | |
| 33 | ✓ | Avenue Therapeutics Inc | Stock-Other | 0.54% | — | — | |
| 34 | BCT1EUR | Briacell Therapeutics CORP | Stock-Other | 0.53% | — | — | |
| 35 | ✓ | Akari Therapeutics PLC | Stock-Other | 0.49% | — | — | |
| 36 | RKDA | Arcadia Biosciences Inc | Stock-Other | 0.48% | -1.77% | EXIT | |
| 37 | ✓ | Stock-Other | 0.48% | — | — | ||
| 38 | ✓ | Reviva Pharmaceutcls Hldgs Inc | Stock-Other | 0.44% | — | — | |
| 39 | IBIO | Ibio Inc | Stock-Other | 0.31% | — | -92.08% | |
| 40 | AMPGW | Amplitech Group Inc-cw26 | Stock-Other | 0.30% | — | -7.60% | |
| 41 | ✓ | Eos Energy Enterprises Inc | Stock-Other | 0.29% | — | — | |
| 42 | CORZZ | Core Scientific Inc - 29 | Stock-Other | 0.19% | — | — | |
| 43 | ✓ | Wearable Devices LTD | Stock-Other | 0.16% | — | -46.19% | |
| 44 | ✓ | Gevo Inc | Stock-Other | 0.14% | — | -80.36% | |
| 45 | SXTPW | 60 Degrees Pharma Inc-28 | Stock-Other | 0.13% | — | — | |
| 46 | ✓ | Invo Bioscience Inc | Stock-Other | 0.11% | — | — | |
| 47 | ✓ | Supercom LTD New | Stock-Other | 0.11% | — | — | |
| 48 | SPIR | Spire Global Inc | Stock-Other | 0.10% | — | — | |
| 49 | CINGW | Cingulate -cw23 | Stock-Other | 0.04% | — | -16.18% | |
| 50 | ✓ | Token Cat LTD | Stock-Other | 0.04% | — | — |
According to official SEC Form 13F filings, Sabby Management, LLC reported a total U.S. public equity portfolio value of $110.5M across 55 disclosed positions in Q1 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
During Q1 2024, Sabby Management, LLC's top holdings by market value included VANI (26.9%)、ELTEK LTD (6.8%)、CORZ 12 01-23-29 (6.8%). The largest single position, VANI, represented 26.9% of total portfolio value.
In Q1 2024, Sabby Management, LLC made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.